|
| A) | Heliotrope rash | ||
| B) | Pruritus of unclear cause | ||
| C) | Telangiectasias | ||
| D) | Livedo reticularis |
| A) | Psoriasiform plaques | ||
| B) | Malar rash | ||
| C) | Erythema nodosum | ||
| D) | Leg ulcers over the medial and lateral malleoli |
| A) | Aspirin use | ||
| B) | Acetaminophen use | ||
| C) | Omeprazole use | ||
| D) | Loratadine use |
| A) | Sunscreen chemicals | ||
| B) | Fluoridated water | ||
| C) | Silicone cookware | ||
| D) | Industrial dyes and dry cleaning fluid |
| A) | Splenectomy | ||
| B) | Hemiarthroplasty | ||
| C) | Cataract removal | ||
| D) | Inguinal hernia repair |
| A) | Cholecystectomy | ||
| B) | Appendectomy | ||
| C) | Resection of the stomach and duodenum | ||
| D) | Hysterectomy |
| A) | Posterior forearm skin | ||
| B) | Cheek coloration | ||
| C) | Palmar creases | ||
| D) | Dorsal foot veins |
| A) | Vesicular lesions that crust within 24 to 48 hours | ||
| B) | Warm, indurated plaques with surrounding pallor | ||
| C) | Tender, raised red papules that blanch with pressure | ||
| D) | Flat, nontender lesions that do not blanch with pressure |
| A) | Hemarthrosis after minor trauma | ||
| B) | Deep muscle hematomas | ||
| C) | Petechiae over pressure areas after a tourniquet or cuff is used | ||
| D) | Chronic epistaxis without cutaneous signs |
| A) | Conjunctival pallor | ||
| B) | Blue sclerae | ||
| C) | Kayser–Fleischer rings | ||
| D) | Subconjunctival hemorrhage only |
| A) | Measuring renal function | ||
| B) | Screening for endocrine disorders | ||
| C) | Assessing oxygen transport and resistance to infection | ||
| D) | Directly measuring clotting factors |
| A) | Simple iron deficiency alone | ||
| B) | Polycythemia vera and sickle cell disease | ||
| C) | Leukemia, malignant lymphoma, and Hodgkin disease | ||
| D) | Uncomplicated dehydration and shock |
| A) | It measures platelet function. | ||
| B) | It detects vitamin B12 status only. | ||
| C) | It is rarely useful in anemia evaluation. | ||
| D) | It is the most useful test in the evaluation of anemia. |
| A) | PT alone | ||
| B) | Bleeding time (IVY method preferred) among other assays | ||
| C) | D dimer only | ||
| D) | ESR and CRP only |
| A) | Bleeding time | ||
| B) | Fibrinogen level alone | ||
| C) | Prothrombin time (PT) | ||
| D) | Partial thromboplastin time (PTT) |
| A) | PT only | ||
| B) | Bleeding time | ||
| C) | Platelet count | ||
| D) | Partial thromboplastin time (PTT) |
| A) | Factor IX activity | ||
| B) | Factor VIII AAHF activity | ||
| C) | Platelet function assay alone | ||
| D) | von Willebrand factor antigen only |
| A) | Recent high iron diet | ||
| B) | Use of beta blockers | ||
| C) | Normal ferritin levels | ||
| D) | Immunizations within the previous six months |
| A) | High ferritin and low TIBC | ||
| B) | Normal ferritin with low TIBC | ||
| C) | High LDH and low bilirubin only | ||
| D) | Decreased serum ferritin and elevated TIBC |
| A) | Trendelenburg position | ||
| B) | Elevate head of bed; administer oxygen therapy as needed | ||
| C) | Strict bedrest supine only | ||
| D) | Hyperventilation coaching |
| A) | Use toothpicks and floss daily. | ||
| B) | Brush firmly to prevent plaque. | ||
| C) | Alcohol mouthwash hourly. | ||
| D) | Use soft bristled toothbrush or cotton swabs; soothing nonalcoholic mouthwashes every two to four hours. |
| A) | 2,500 cells/mcL | ||
| B) | 1,200 cells/mcL | ||
| C) | 800 cells/mcL | ||
| D) | Less than 500 cells/mcL |
| A) | Group A | ||
| B) | Group B | ||
| C) | Group AB | ||
| D) | Group O |
| A) | Avoid giving Rh– RBCs to Rh+ recipients | ||
| B) | Avoid transfusing Rh+ RBCs into Rh– girls and women during pregnancy or childbirth | ||
| C) | Rh status is irrelevant to future pregnancies | ||
| D) | Rh+ units can be given to all recipients safely |
| A) | Minor crossmatch | ||
| B) | Major crossmatch (recipient plasma with donor RBCs) | ||
| C) | Type and screen only replaces crossmatch | ||
| D) | Visual inspection for clots only |
| A) | Whole blood is routine | ||
| B) | Granulocytes never used | ||
| C) | Only plasma is transfused | ||
| D) | Component therapy (RBCs, plasma, platelets, cryoprecipitate), with WBCs removed |
| A) | correct low hemoglobin specifically. | ||
| B) | prevent/treat bleeding due to thrombocytopenia or platelet dysfunction. | ||
| C) | reverse elevated PT only. | ||
| D) | treat iron deficiency. |
| A) | DIC with hemorrhage when fibrinogen <1 g/L | ||
| B) | Mild PT elevation without bleeding | ||
| C) | Platelet count 120,000/mcL | ||
| D) | Prophylaxis before vaccinations |
| A) | Use non filtered primary tubing | ||
| B) | Prime with D5W through any IV tubing | ||
| C) | Prime Y set with 0.9% normal saline and do not co administer medications in the same line | ||
| D) | Prime with LR and piggyback antibiotics |
| A) | Two hours | ||
| B) | Three hours | ||
| C) | Four hours | ||
| D) | Six hours |
| A) | Single nurse visual check | ||
| B) | Patient verbally states blood type | ||
| C) | Two qualified nurses verify patient ID, blood unit, and compatibility | ||
| D) | Physician signature replaces nurse verification |
| A) | 25–50 mL/min | ||
| B) | 1–2 mL/min (10–20 gtt/min) with the nurse remaining with the patient | ||
| C) | Run wide open if vitals are stable | ||
| D) | 5–10 mL/min without monitoring |
| A) | Increase the infusion rate | ||
| B) | Give acetaminophen and continue | ||
| C) | Call the lab before changing anything | ||
| D) | Stop the infusion and switch to 0.9% NS with new primed tubing |
| A) | Lower back | ||
| B) | Knee/shin area | ||
| C) | Hips | ||
| D) | All of the above |
| A) | Daily aspirin | ||
| B) | Hydroxyurea, which induces fetal hemoglobin and reduces pain crises and transfusions | ||
| C) | Routine phlebotomy | ||
| D) | Long term corticosteroids alone |
| A) | With a trigger of lactose, manage with epinephrine. | ||
| B) | With the trigger fava beans/certain drugs, manage with trigger avoidance and transfuse packed RBCs, if severe. | ||
| C) | With a trigger of gluten, manage with steroid therapy. | ||
| D) | With a trigger of aspirin, manage with splenectomy only. |
| A) | Prolonged PT, low platelets | ||
| B) | Normal PT and platelet count with prolonged PTT | ||
| C) | Elevated fibrinogen, prolonged bleeding time only | ||
| D) | Low factor VII with prolonged PT only |
| A) | Aspirin for analgesia | ||
| B) | Early aggressive ROM | ||
| C) | Splinting or casting the involved joint; administer deficient factor | ||
| D) | Heat and deep massage |
| A) | A short course of B12 is sufficient. | ||
| B) | Lifelong vitamin B12 therapy is required; noncompliance risks neurologic damage. | ||
| C) | Iron alone reverses anemia. | ||
| D) | Therapy can stop once hemoglobin normalizes. |
| A) | Acute myeloid leukemia (AML) | ||
| B) | Acute lymphocytic leukemia (ALL) | ||
| C) | Chronic lymphocytic leukemia (CLL) | ||
| D) | Large granular lymphocytic leukemia (LGL) |